adjuvants :: Article Creator Global Vaccine Adjuvants Market To Reach $1.5 Billion By 2030 ReportLinker The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. New York, April 17, 2023 (GLOBE NEWSWIRE) -- Reportlinker.Com announces the release of the report "Global Vaccine Adjuvants Industry" - https://www.Reportlinker.Com/p06043964/?Utm_source=GNWFood and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investmen...
Get link
Facebook
X
Pinterest
Email
Other Apps
New TB Vaccine For Adults In The Works - Medical Daily
Get link
Facebook
X
Pinterest
Email
Other Apps
-
The existing vaccine for tuberculosis (TB) only works for very young children. This makes it difficult for public health officials and healthcare providers to combat the infection in older people.
But a new study conducted in Africa found a vaccine that could prevent TB from spreading among adults. Researchers tested the approach in nearly 3,600 patients in Kenya, Zambia and South Africa.
The participants were divided into groups, with one receiving two doses of the TB vaccine every other month and another group that took dummy shots. Researchers then followed the participants for three years.
By the end of the study, researchers said the vaccine was 50 percent effective at preventing latent TB infection from turning into active disease. In the vaccine group, only 13 people developed active TB, while 26 in the placebo group had the disease.
The TB vaccine for adults, described in the New England Journal of Medicine, was developed by pharmaceutical company GlaxoSmithKline in the United Kingdom. Researchers said tests showed "the vaccine is holding up" over time.
The protection provided by the vaccine against TB also declined only a little after two years. Paula Fujiwara, scientific director of the International Union Against Tuberculosis and Lung Disease, said the study helps scientists to move closer to a prevention tool that has been sought for 100 years, Fox Business reported Tuesday.
The World Health Organization (WHO) also recognized the new TB vaccine for adults as a major breakthrough. The organization recently held meetings to discuss its development.
TB And Its Effects In U.S.
The new vaccine that appears effective against latent TB infection may also work in many Americans. There are 13 million people living with such form of infection in the U.S., according to the Centers for Disease Control and Prevention (CDC).
Untreated latent TB infection has been linked to more than 80 percent of TB cases across the country.
Although anyone can get TB, some people have a higher risk of being infected with TB germs, and should be tested for TB infection.
People born in or who frequently travel to countries where TB disease is common, and people with weaker immune systems, taking certain medications, working in hospitals or living in homeless shelters and other usually crowded areas have high risk of developing the disease.
A new study conducted in Africa found a vaccine that could prevent TB from spreading among adults.Pixabay
prepmod vaccine :: Article Creator What Went Wrong With The 'Tiny Nonprofit' Behind The State's Beleaguered Vaccine Site When Gov. Charlie Baker released vaccine eligibility to a million more Massachusetts residents last week, state websites crumpled under a virtual stampede of people rushing to secure appointments. Users were left in online limbo for hours, and many gaped at how something so critical could be entrusted to, in their eyes, flimsy web services and fragile program designs. "Foolish system. Ill-Designed. Who are the people that designed it?" seethed Steve Rosenfeld, 70, from Worcester in a written comment to WBUR after he failed to get an appointment. The nonprofit Maryland Partnership for Prevention runs one of the crucial websites that crashed last week, a service it provides in more than two dozen states across the country. The company's software allows people to register their COVID-19 vaccines and make a...
arthritis osteoporosis and rheumatology associates :: Article Creator Arthritis & Rheumatology Clinic Contact Information Arthritis & Rheumatology Clinic 740 Jordan Street, Shreveport, LA 71101 Office: (318) 424-9240 Fax: (318) 424-0022 www.Arthdoc.Com Find us on Facebook About Dr. Goodman Robert E. Goodman, M.D. Board-Certified Rheumatologist "Blending the most innovative approaches in rheumatology and arthritis treatments with personalized patient care" Board Certified Rheumatologist Robert E. Goodman, M.D., of the Arthritis and Rheumatology Clinic in Shreveport, has been caring for patients in the Ark-La-Tex since 1985. Dr. Goodman combines his specialized training and experience with personalized care to provide patients with leading-edge technology and the latest treatment options. Dr. Goodman and the Arthritis & Rheumatology Clinic Healthcare Team of caring, compassionate healthcare professiona...
Comments
Post a Comment